Last reviewed · How we verify

NCT06340997

Impact of Percutaneous Transvenous Mitral Commissurotomy on The Left Atrial Appendage Function in Patients With Mitral Stenosis.

Not yet recruiting NA Last updated 2 April 2024
What this trial tests

NA trial testing Transesophageal echocardiography in Mitral Stenosis in 25 participants. Not yet recruiting.

Timeline
1 July 2024
Primary endpoint
1 October 2026
1 August 2027

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment25
Start date1 July 2024
Primary completion1 October 2026
Estimated completion1 August 2027

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Mitral Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

• Evaluation of the effect of PTMC on LAA function by TEE at least one month after the procedure and its effectiveness in prevention of thrombi formation and cerebrovascular complications.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transesophageal echocardiography

Trials testing the same drug.

Other recruiting trials for Mitral Stenosis

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06340997.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing